Holen Sie sich die Stockscreener-App
11.56
1.85%
0.21
Handel nachbörslich:
11.70
0.14
+1.21%
Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten
Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy' - MSN
Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year LowWhat's Next? - MarketBeat
State Street Corp Buys 322,156 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Franklin Resources Inc. Cuts Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
State Street Corp Has $57.29 Million Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock faces pivotal year - Investing.com
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap UpWhat's Next? - MarketBeat
Jefferies Financial Group Initiates Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) - MarketBeat
Head-To-Head Review: InMed Pharmaceuticals (NASDAQ:INM) & Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World
RTW INVESTMENTS, LP Increases Stake in Rocket Pharmaceuticals Inc - GuruFocus.com
(RCKT) Trading Report - Stock Traders Daily
Synovus Financial Corp Decreases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Leerink Partnrs Has Positive Outlook of RCKT FY2024 Earnings - MarketBeat
FY2024 Earnings Estimate for RCKT Issued By Leerink Partnrs - Defense World
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com Australia
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 1-Year LowHere's What Happened - MarketBeat
Rocket Pharmaceuticals completes $178.1 million offering - Investing.com India
Rocket Pharmaceuticals completes $178.1 million offering By Investing.com - Investing.com Australia
RSI Alert: Rocket Pharmaceuticals (RCKT) Now Oversold - Nasdaq
RCKT Stock Hits 52-Week Low at $12.62 Amid Market Challenges - Investing.com India
RCKT Stock Hits 52-Week Low at $12.62 Amid Market Challenges By Investing.com - Investing.com South Africa
Fmr LLC Lowers Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals sets $12.50 share price for offering By Investing.com - Investing.com South Africa
Watkins Advises on Rocket Pharmaceuticals’ Upsized Public Offering of Common Stock - Latham & Watkins LLP
Rocket Pharmaceuticals sets $12.50 share price for offering - Investing.com India
Rocket Pharmaceuticals Secures $165M Through Upsized Public Stock Offering at $12.50 Per Share - StockTitan
Rocket Pharmaceuticals plans $150 million stock offering By Investing.com - Investing.com Canada
Point72 Asset Management L.P. Acquires Shares of 48,096 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals plans $150 million stock offering - Investing.com India
Rocket Pharmaceuticals Plans $150 Million Public Offering of Common Shares - Marketscreener.com
Rocket Pharmaceuticals Launches $150M Public Offering to Advance Genetic Therapy Pipeline - StockTitan
Frazier Life Sciences Management L.P. Sells 75,600 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Wellington Management Group LLP Acquires 2,086,424 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Janus Henderson Group PLC Has $35.06 Million Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
(RCKT) Investment Report - Stock Traders Daily
44,700 Shares in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Purchased by Erste Asset Management GmbH - MarketBeat
Walleye Capital LLC Buys New Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Rocket Pharmaceuticals Offers Huge Potential as Price Targets Exceed 300% Growth - TheStreet
Bamco Inc. NY Sells 94,990 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals: Not Bad Valuation But Reflexivity Risks Remain (RCKT) - Seeking Alpha
RCKT (Rocket Pharmaceuticals) Price-to-Operating-Cash-Flow : (As of Nov. 30, 2024) - GuruFocus.com
RCKT (Rocket Pharmaceuticals) Cash From Other Investing Act - GuruFocus.com
RCKT (Rocket Pharmaceuticals) PE Ratio without NRI : At Loss (As of Nov. 29, 2024) - GuruFocus.com
RCKT (Rocket Pharmaceuticals) Cash, Cash Equivalents, Marke - GuruFocus.com
RCKT (Rocket Pharmaceuticals) Price-to-Free-Cash-Flow : N/A (As of Nov. 28, 2024) - GuruFocus.com
RCKT (Rocket Pharmaceuticals) 50-Day SMA : $16.76 (As of Nov. 28, 2024) - GuruFocus.com
Acuta Capital Partners LLC Sells 60,370 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
3 Small-Cap Stocks That Are Ready to Rocket Higher - sharewise
Fiverr International Ltd (FVRR-N) QuotePress Release - The Globe and Mail
General Motors Company (GM-N) QuotePress Release - The Globe and Mail
Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference - BioSpace
Rocket Pharmaceuticals CEO to Present at Evercore HealthCONx Conference - StockTitan
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):